Interventional Pulmonology Market 2023 Global Key Players, Market Dynamics, Future Demand Analysis and Forecasts to 2033

The interventional pulmonology market has experienced significant growth in recent years, driven by several factors such as the increasing prevalence of respiratory diseases, advancements in diagnostic and therapeutic techniques, and the rising demand for minimally invasive procedures in pulmonology. Interventional pulmonology involves the use of advanced bronchoscopic procedures to diagnose and treat various respiratory conditions, including lung cancer, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.

Various awareness programs have been initiated by healthcare providers and health organizations/societies such as environmental programs, medication maintenance programs, and online education programs for public and healthcare professionals across the globe to control asthma, COPD, and other respiratory diseases. Major companies such as Boston Scientific Corporation, Olympus Corporation, and FUJIFILM Corporation, besides others, are focused on spreading awareness regarding respiratory diseases.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12544

Companies covered in Interventional Pulmonology Market Report

• Medtronic Plc
• Boston Scientific Corporation
• Olympus Corporation
• FUJIFILM Corporation
• Becton, Dickinson and Company
• Smiths Group Plc
• Cook Medical
• Vygon
• Clarus Medical LLC
• Huger Medical Instrument Co. Ltd
• Taewoong Medical Co. Ltd.
• Shanghai AoHua Photoelectricity Endoscope Co., Ltd
• Karl Storz
• Richard Wolf Corporation
• PENTAX Medical

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12544

Worldwide revenue from the interventional pulmonology market stands at US$ 1.2 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 4.2% to reach a valuation of US$ 1.9 Bn by the end of 2033.

Competition Landscape

Due to industry consolidation, major players are focusing more on acquiring local and regional market players. This trend has been especially evident in the Asia-Pacific region. Big players in the acquisition space are players with sizable regional distribution networks in terms of direct sales force and equipped manufacturing facilities for interventional pulmonary treatment products.

Key instances include:

• In Aug 2020, The BF-Q180 bronchoscope from Olympus Corporation was recalled because it failed a 510(k) clearance and was linked to a greater rate of patient infections than other bronchoscopes from Olympus Medical Systems Corporation.
• In May 2020, the introduction of artificial intelligence, high definition image, and sophisticated data processing were few of the accomplishments and initiatives that Fujifilm Holdings Corporation announced in relation to the expansion of their endoscopy and endoscopic health portfolio.

Immediate Purchase Full Report @ https://www.persistencemarketresearch.com/checkout/12544

Acquisitions of Small & Medium Players – Imperative Strategy for Market Players

Given the consolidation in the market, bigger players are focusing on the acquisition of small and medium market players. This trend is being observed across North America and Europe. This is dominated by players with a strong regional distribution presence in terms of direct sales force and medical ventilator product manufacturing.

What else is in the report?

Persistence Market Research offers actionable insights and unique perspective on the interventional pulmonology market in its latest study, presenting historical demand assessment of 2016 – 2019 and projections for 2021–2031, based on product (Electromagnetic Navigation Bronchoscopy (ENB), IP Diagnostic Devices, IP therapeutic devices), indication (Asthma, Lung Cancer, COPD, Foreign Body Extraction, Tracheal and Bronchial Stenosis), and end user (Hospitals, Pulmonology Clinics, Ambulatory Surgical Centers, Diagnostic Centers), across seven key regions of the world.